BATS BZX Real-Time Price
As of 1:27pm ET
| +0.015 / +0.68%|
The 5 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +56.60% increase from the last price of 2.24.
The current consensus among 5 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.